Cargando…
Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation
The aberrant function of chromatin regulatory networks (epigenetics) is a hallmark of cancer promoting oncogenic gene expression. A growing body of evidence suggests that the disruption of specific chromatin-associated protein complexes has therapeutic potential in malignant conditions, particularly...
Autores principales: | Perner, Florian, Armstrong, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767226/ https://www.ncbi.nlm.nih.gov/pubmed/33371192 http://dx.doi.org/10.3390/cells9122721 |
Ejemplares similares
-
Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention
por: Uckelmann, Hannah J., et al.
Publicado: (2020) -
Differentiation therapy for myeloid malignancies: beyond cytotoxicity
por: Stubbins, Ryan J., et al.
Publicado: (2021) -
Chromatin Evolution-Key Innovations Underpinning Morphological Complexity
por: Hajheidari, Mohsen, et al.
Publicado: (2019) -
Targeting Chromatin Regulation in Acute Myeloid Leukemia
por: Richardson, Simon E., et al.
Publicado: (2021) -
Embracing basic and clinical innovation in hepatology
por: Schwabe, Robert F.
Publicado: (2019)